文献速递膀胱癌与上尿路尿路上皮癌前列腺增生与排尿功能障碍

加速康复方案对机器人辅助根治性膀胱切除加体内尿流改道术后衰弱患者的影响

Impact of an enhanced recovery protocol in frail patients after intracorporeal urinary diversion.
PubMed 文献 · BJU Int · 2024-03-19

这项回顾性队列研究纳入2012至2023年间接受机器人辅助根治性膀胱切除加体内尿流改道的186例患者(104例接受加速康复方案,82例未接受)。结果显示,加速康复方案在整体队列和非衰弱患者中缩短住院时间、促进肠道恢复并降低术后肠梗阻发生率,但在衰弱患者中未降低术后肠梗阻发生率(44.1% vs 36.6%;P=0.50)。

要点

  • 非衰弱患者中,加速康复组术后肠梗阻发生率低于非加速康复组(7.1% vs 22.1%;P=0.008)。
  • 衰弱患者中,加速康复方案未降低术后肠梗阻发生率(44.1% vs 36.6%;P=0.50)。
  • 多因素分析中,加速康复方案在整体队列(OR 0.39,P=0.01)和非衰弱患者(OR 0.24,P=0.01)中与术后肠梗阻风险降低相关,但在衰弱患者中未显示降低风险(OR 1.14,P=0.70)。

核心结论

  • 加速康复方案未降低衰弱患者接受机器人辅助根治性膀胱切除加体内尿流改道术后的术后肠梗阻发生率,但促进了非衰弱患者的肠道恢复并降低了术后肠梗阻发生率。
  • 作者认为,对衰弱患者进行预康复可能降低术后肠梗阻发生率。

研究设计与样本

  • 回顾性队列研究,纳入2012至2023年间接受机器人辅助根治性膀胱切除加体内尿流改道的186例患者,其中104例接受加速康复方案,82例未接受。
  • 衰弱定义为老年-8问卷评分≤13分。
  • 主要结局为术后肠道恢复和术后肠梗阻发生率;次要结局包括住院时间、30天和90天并发症、90天再入院率及术后肠梗阻预测因素。

主要发现

  • 在整体队列中,加速康复组较非加速康复组住院时间更短、肠道恢复更早、术后肠梗阻发生率更低、90天高级别并发症更少、90天再入院更少。
  • 非衰弱患者中,加速康复组术后肠梗阻发生率低于非加速康复组(7.1% vs 22.1%;P=0.008)。
  • 衰弱患者中,加速康复方案未降低术后肠梗阻发生率(44.1% vs 36.6%;P=0.50)。
  • 多因素分析中,加速康复方案在整体队列中与术后肠梗阻风险降低相关(OR 0.39,P=0.01),在非衰弱患者中同样相关(OR 0.24,P=0.01),但在衰弱患者中未显示降低风险(OR 1.14,P=0.70)。
  • 预康复被确定为术后肠梗阻的有利预测因素。

临床怎么用

  • 作者认为,对衰弱患者进行预康复可能降低术后肠梗阻发生率。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine whether an enhanced recovery after surgery (ERAS) protocol enhances bowel recovery and reduces postoperative ileus (POI) in both non-frail and frail patients after robot-assisted radical cystectomy with intracorporeal urinary diversion (iRARC). PATIENTS AND METHODS: This retrospective cohort study included 186 patients (104 with and 82 without ERAS) who underwent iRARC between 2012 and 2023. 'Frail' patients was defined as those with a low Geriatric-8 questionnaire score (≤13). The primary outcomes were postoperative bowel recovery and the incidence of POI. Secondary outcomes included length of stay (LOS), 30- and 90-day complications, 90-day readmission rate, and POI predictors. RESULTS: The ERAS group exhibited a significantly shorter LOS, early bowel recovery, a lower POI rate, fewer 90-day high-grade complications, and fewer 90-day readmissions than the non-ERAS group in the entire cohort. Non-frail patients in the ERAS group had a lower rate of POI (7.1% vs. 22.1%; P = 0.008), whereas ERAS did not reduce POI in frail patients (44.1% vs. 36.6%; P = 0.50). In the multivariate analysis, ERAS was associated with a reduced risk of POI in both the entire cohort (odds ratio [OR] 0.39, P = 0.01) and in non-frail patients (OR 0.24, P = 0.01), whereas ERAS was not likely to reduce POI (OR 1.14, P = 0.70) in frail patients. Prehabilitation was identified as a favourable predictor of POI. CONCLUSIONS: The ERAS protocol did not reduce POI in frail patients after iRARC, although it enhanced bowel recovery and reduced POI in non-frail patients. Prehabilitation for frail patients might reduce POI.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Zennami K, Kusaka M, Tomozawa S, et al. Impact of an enhanced recovery protocol in frail patients after intracorporeal urinary diversion. BJU Int. 2024. PMID: 38500447. doi:10.1111/bju.16340

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。